THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Ravi Kode to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Ravi Kode has written about Antibodies, Monoclonal.
Ravi Kode
Connection Strength
0.433
Antibodies, Monoclonal
  1. Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. Clin Transplant. 2003 Aug; 17(4):369-76.
    View in: PubMed
    Score: 0.190
  2. Simulect induction significantly decreases CMV infection in kidney recipients compared to OKT3. Transplant Proc. 2001 Feb-Mar; 33(1-2):1268-9.
    View in: PubMed
    Score: 0.160
  3. Simulect, Neoral, Cellcept, and prednisone in kidney recipients with delayed graft function: a prospective controlled study. Transplant Proc. 2001 Nov-Dec; 33(7-8):3762-3.
    View in: PubMed
    Score: 0.042
  4. Induction strategy using basiliximab combined with mycophenolate MMF and immediate low-dose cyclosporin is steroid sparing and more effective than OKT3. Transplant Proc. 2001 Feb-Mar; 33(1-2):1057-8.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES